1.1 List of Tables 7
1.2 List of Figures 8

2 Introduction 9
2.1 Clinical Chemistry Alyzers Overview 9

3 Products under Development 10
3.1 Clinical Chemistry Alyzers - Pipeline Products by Stage of Development 10
3.2 Clinical Chemistry Alyzers - Pipeline Products by Segment 11
3.3 Clinical Chemistry Alyzers - Pipeline Products by Territory 12
3.4 Clinical Chemistry Alyzers - Pipeline Products by Regulatory Path 13
3.5 Clinical Chemistry Alyzers - Pipeline Products by Estimated Approval Date 14
3.6 Clinical Chemistry Alyzers - Ongoing Clinical Trials 15

4 Clinical Chemistry Alyzers - Pipeline Products under Development by Companies 16
4.1 Clinical Chemistry Alyzers Companies - Pipeline Products by Stage of Development 16
4.2 Clinical Chemistry Alyzers - Pipeline Products by Stage of Development 17

5 Clinical Chemistry Alyzers Companies and Product Overview 18
5.1 Abreos Biosciences Inc Company Overview 18
5.1.1 Abreos Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 18
5.2 Advanced Liquid Logic Inc Company Overview 20
5.2.1 Advanced Liquid Logic Inc Pipeline Products & Ongoing Clinical Trials Overview 20
5.3 All Medicus Co Ltd Company Overview 21
5.3.1 All Medicus Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 21
5.4 Arogyam Medisoft Solution Pvt Ltd Company Overview 22
5.4.1 Arogyam Medisoft Solution Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 22
5.5 AutoGenomics Inc Company Overview 23
5.5.1 AutoGenomics Inc Pipeline Products & Ongoing Clinical Trials Overview 23
5.6 Aviv Biomedical, Inc. Company Overview 25
5.6.1 Aviv Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
5.7 Curetis NV Company Overview 28
5.7.1 Curetis NV Pipeline Products & Ongoing Clinical Trials Overview 28
5.8 Daxor Corp Company Overview 29
5.8.1 Daxor Corp Pipeline Products & Ongoing Clinical Trials Overview 29
5.9 DiaSys Diagnostic Systems GmbH Company Overview 30
5.9.1 DiaSys Diagnostic Systems GmbH Pipeline Products & Ongoing Clinical Trials Overview 30
5.10 EKF Diagnostics Holdings Plc Company Overview 31
5.10.1 EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview 31
5.11 Emergent Detection Inc (Ictive) Company Overview 33
5.11.1 Emergent Detection Inc (Ictive) Pipeline Products & Ongoing Clinical Trials Overview 33
5.12 Hansjorg Wyss Institute for Biologically Inspired Engineering Company Overview 34
5.12.1 Hansjorg Wyss Institute for Biologically Inspired Engineering Pipeline Products & Ongoing Clinical Trials Overview 34
5.13 Hitachi Chemical Co Ltd Company Overview 35
5.13.1 Hitachi Chemical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 35
5.14 Invivomon Inc (Ictive) Company Overview 36
5.14.1 Invivomon Inc (Ictive) Pipeline Products & Ongoing Clinical Trials Overview 36
5.15 Luminex Corp Company Overview 37
5.15.1 Luminex Corp Pipeline Products & Ongoing Clinical Trials Overview 37
5.16 MyCartis NV Company Overview 38
5.16.1 MyCartis NV Pipeline Products & Ongoing Clinical Trials Overview 38
5.17 noIVD Inc Company Overview 39
5.17.1 noIVD Inc Pipeline Products & Ongoing Clinical Trials Overview 39
5.18 Ortho-Clinical Diagnostics Inc Company Overview 40
5.18.1 Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 40
5.19 Smiths Diagnostics Medical Company Overview 41
5.19.1 Smiths Diagnostics Medical Pipeline Products & Ongoing Clinical Trials Overview 41
5.20 The Hong Kong University of Science and Technology Company Overview 42
5.20.1 The Hong Kong University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview 42
5.21 Theranos Inc Company Overview 43
5.21.1 Theranos Inc Pipeline Products & Ongoing Clinical Trials Overview 43
5.22 Thermal Gradient Inc Company Overview 44
5.22.1 Thermal Gradient Inc Pipeline Products & Ongoing Clinical Trials Overview 44
5.23 Thermo Fisher Scientific Inc Company Overview 45
5.23.1 Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 45

6 Clinical Chemistry Alyzers- Recent Developments 46
6.1 Nov 05, 2019: BD announces results for 2019 fourth fiscal quarter and full year; provides fiscal 2020 guidance 46
6.2 Nov 04, 2019: Luminex reports third quarter 2019 results and submission of VERIGENE II Gastrointestil Flex Assay to the FDA 47
6.3 Oct 31, 2019: Bio-Rad reports third-quarter 2019 fincial results 48
6.4 Oct 31, 2019: Bio-Rad reports third-quarter 2019 fincial results. 49
6.5 Oct 30, 2019: PerkinElmer announces fincial results for the third quarter of 2019 50
6.6 Oct 30, 2019: QIAGEN reports full results for third quarter and first nine months of 2019 51
6.7 Oct 29, 2019: Illumi celebrates grand opening of its solutions center in the University of Maryland BioPark 54
6.8 Oct 29, 2019: ELITechGroup announces direct sales and customer support in Cada 55
6.9 Oct 29, 2019: Exact Sciences reports third-quarter revenue growth of 85 percent to $219 million 55
6.10 Oct 28, 2019: Siemens announces new magement team for Siemens Energy 56

7 Appendix 216
7.1 Methodology 216
7.2 About GlobalData 219
7.3 Contact Us 219
7.4 Disclaimer 219